Pictet Asset Management (Switzerland)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,739
| Closed | -$215K | – | 2034 |
|
|
2022
Q4 | $215K | Sell |
4,739
-236,241
| -98% | -$10.7M | ﹤0.01% | 1692 |
|
|
2022
Q3 | $16.8M | Buy |
240,980
+2,033
| +0.9% | +$142K | 0.03% | 465 |
|
|
2022
Q2 | $16M | Sell |
238,947
-140,129
| -37% | -$9.41M | 0.02% | 494 |
|
|
2022
Q1 | $31.2M | Buy |
379,076
+78,807
| +26% | +$6.48M | 0.04% | 396 |
|
|
2021
Q4 | $44M | Buy |
300,269
+50,164
| +20% | +$7.36M | 0.04% | 363 |
|
|
2021
Q3 | $44.2M | Buy |
+250,105
| New | +$44.2M | 0.05% | 355 |
|